Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kaimei Huang"'
Autor:
Pengshuo Yang, Jialiang Yang, Haixia Long, Kaimei Huang, Lei Ji, Hanyang Lin, Xiuli Jiang, Arthur Kairui Wang, Geng Tian, Kang Ning
Publikováno v:
iMeta, Vol 2, Iss 4, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/5c6e5a185c9c4270a524fd2314a4bd03
Autor:
Yi Niu, Lixia Wang, Xiaojie Zhang, Yu Han, Chunjie Yang, Henan Bai, Kaimei Huang, Changjing Ren, Geng Tian, Shengjie Yin, Yan Zhao, Ying Wang, Xiaoli Shi, Minghui Zhang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Tumor mutation burden (TMB) is an important biomarker for tumor immunotherapy. It plays an important role in the clinical treatment process, but the gold standard measurement of TMB is based on whole exome sequencing (WES). WES cannot be done in most
Externí odkaz:
https://doaj.org/article/bc8fd9252df84b0e962b57f33f2de197
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Colorectal cancer (CRC) is one of the most prevalent malignancies, and immunotherapy can be applied to CRC patients of all ages, while its efficacy is uncertain. Tumor mutational burden (TMB) is important for predicting the effect of immunotherapy. C
Externí odkaz:
https://doaj.org/article/ad59c0bd27cd4219b692d014012eccae
Publikováno v:
IEEE Access, Vol 8, Pp 26190-26198 (2020)
In recent years, it has been increasingly clear that long non-coding RNAs (lncRNAs) are able to regulate their target genes at multi-levels, including transcriptional level, translational level, etc and play key regulatory roles in many important bio
Externí odkaz:
https://doaj.org/article/c1cceb90a7fc4854ae85609373938db9
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Lung cancer is a kind of cancer with high morbidity and mortality which is associated with various gene mutations. Individualized targeted-drug therapy has become the optimized treatment of lung cancer, especially benefit for patients who are not qua
Externí odkaz:
https://doaj.org/article/9b4ec1788a2846199fa85edb52eb9b8f
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Cancer immunotherapy, as a novel treatment against cancer metastasis and recurrence, has brought a significantly promising and effective therapy for cancer treatments. At present, programmed death 1 (PD-1) and programmed cell death-Ligand 1 (PD-L1) t
Externí odkaz:
https://doaj.org/article/8113045e9bd64b86aea3da9d94e6b7dc
Publikováno v:
Bioinformatics (Oxford, England). 38(22)
Motivation Tumor mutational burden (TMB) is an indicator of the efficacy and prognosis of immune checkpoint therapy in colorectal cancer (CRC). In general, patients with higher TMB values are more likely to benefit from immunotherapy. Though whole-ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41ce49f3908e2d8f22a9d2845ec2d2d0
https://pubmed.ncbi.nlm.nih.gov/36130268
https://pubmed.ncbi.nlm.nih.gov/36130268
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Lung cancer is a kind of cancer with high morbidity and mortality which is associated with various gene mutations. Individualized targeted-drug therapy has become the optimized treatment of lung cancer, especially benefit for patients who are not qua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9de4179c90729dda20168e52ce9e443b
https://pubmed.ncbi.nlm.nih.gov/33928031
https://pubmed.ncbi.nlm.nih.gov/33928031